# A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

> **NCT00800176** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 394 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Placebo
- **DRUG:** RO4998452
- **DRUG:** RO4998452
- **DRUG:** RO4998452
- **DRUG:** RO4998452
- **DRUG:** RO4998452

## Key facts

- **NCT ID:** NCT00800176
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-22
- **Primary completion:** 2009-10-28
- **Final completion:** 2009-10-28
- **Target enrollment:** 394 (ACTUAL)
- **Last updated:** 2020-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800176, "A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00800176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*